Insider Stock Trading History of Protopapas Anna


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Protopapas Anna since year 2005. The trader's CIK number is 1347582. At the time of this reporting, Protopapas Anna is the President and CEO of Mersana Therapeutics, Inc. . (stock ticker symbol MRSN). See this page for all insider trading activities at Mersana Therapeutics, Inc. .

Note that in the past Protopapas Anna also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Protopapas Anna since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-12-20 MRSN Mersana Therapeutics, Inc. Option Ex 10,417 1.53 15,938
2008-05-01 MLNM Millennium Pharmaceuticals Inc Sale 2,041 24.88 50,780
2008-03-07 MLNM Millennium Pharmaceuticals Inc Sale 2,010 13.34 26,811
2008-02-29 MLNM Millennium Pharmaceuticals Inc Sale 4,289 13.67 58,647
2008-02-19 MLNM Millennium Pharmaceuticals Inc Option Ex 3,561 8.12 28,933
2008-02-19 MLNM Millennium Pharmaceuticals Inc Sale 3,561 14.03 49,960
2008-01-18 MLNM Millennium Pharmaceuticals Inc Option Ex 3,812 8.12 30,972
2008-01-18 MLNM Millennium Pharmaceuticals Inc Sale 3,812 16.53 63,012
2008-01-08 MLNM Millennium Pharmaceuticals Inc Sale 1,071 15.23 16,311
2008-01-03 MLNM Millennium Pharmaceuticals Inc Sale 4,091 16.11 65,906
2007-12-17 MLNM Millennium Pharmaceuticals Inc Option Ex 143,750 11.51 1,654,562
2007-12-03 MLNM Millennium Pharmaceuticals Inc Sale 5,674 14.55 82,556
2007-11-26 MLNM Millennium Pharmaceuticals Inc Sale 5,000 14.32 71,600
2007-11-19 MLNM Millennium Pharmaceuticals Inc Sale 5,000 13.62 68,100
2007-11-12 MLNM Millennium Pharmaceuticals Inc Sale 5,000 13.41 67,050
2007-11-05 MLNM Millennium Pharmaceuticals Inc Sale 5,000 12.62 63,099
2007-11-01 MLNM Millennium Pharmaceuticals Inc Sale 368 12.00 4,416
2007-09-17 MLNM Millennium Pharmaceuticals Inc Option Ex 25,674 4.91 125,956
2007-05-01 MLNM Millennium Pharmaceuticals Inc Sale 1,929 11.07 21,354
2007-04-09 MLNM Millennium Pharmaceuticals Inc Option Ex 4,250 6.88 29,240
2007-04-09 MLNM Millennium Pharmaceuticals Inc Sale 4,250 11.56 49,130
2007-04-02 MLNM Millennium Pharmaceuticals Inc Sale 4,250 11.40 48,450
2007-04-02 MLNM Millennium Pharmaceuticals Inc Option Ex 4,250 6.88 29,240
2007-03-26 MLNM Millennium Pharmaceuticals Inc Sale 4,250 11.38 48,365
2007-03-26 MLNM Millennium Pharmaceuticals Inc Option Ex 4,250 6.88 29,240
2007-03-26 MLNM Millennium Pharmaceuticals Inc Sale 4,250 11.38 48,365
2007-03-26 MLNM Millennium Pharmaceuticals Inc Option Ex 4,250 6.88 29,240
2007-03-19 MLNM Millennium Pharmaceuticals Inc Option Ex 4,088 7.99 32,663
2007-03-19 MLNM Millennium Pharmaceuticals Inc Sale 4,088 10.73 43,864
2007-03-09 MLNM Millennium Pharmaceuticals Inc Option Ex 3,833 2.27 8,697
2007-03-09 MLNM Millennium Pharmaceuticals Inc Sale 3,833 10.59 40,572
2007-03-12 MLNM Millennium Pharmaceuticals Inc Sale 1,970 10.64 20,960
2007-01-04 MLNM Millennium Pharmaceuticals Inc Sale 4,524 11.02 49,854
2006-11-01 MLNM Millennium Pharmaceuticals Inc Sale 436 11.64 5,075

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Protopapas Anna (President and CEO of Mersana Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.